Edition:
United States

Bayer AG (BAYGn.DE)

BAYGn.DE on Xetra

98.79EUR
23 Apr 2018
Change (% chg)

€-0.21 (-0.21%)
Prev Close
€99.00
Open
€99.04
Day's High
€99.25
Day's Low
€98.11
Volume
2,034,746
Avg. Vol
2,956,591
52-wk High
€123.90
52-wk Low
€88.81

Chart for

About

Bayer AG is a life science company. The Company's segments are Pharmaceuticals, Consumer Health, Animal Health and Covestro. The Pharmaceuticals segment focuses on prescription products, especially for cardiology and women's healthcare, and on specialty therapeutics in the areas of oncology, hematology and ophthalmology. The... (more)

Overall

Beta: 1.02
Market Cap(Mil.): €81,867.84
Shares Outstanding(Mil.): 826.95
Dividend: 2.80
Yield (%): 2.83

Financials

  BAYGn.DE Industry Sector
P/E (TTM): 26.52 31.01 33.60
EPS (TTM): 3.72 -- --
ROI: 5.26 13.60 13.19
ROE: 9.68 15.26 15.00

Russian nod moves Bayer closer to wrapping up Monsanto deal

FRANKFURT Russia's antitrust regulator FAS has approved Bayer's planned takeover of Monsanto , the German drugs and crop chemicals maker said, as it enters the home stretch to closing the $62.5 billion deal.

Apr 20 2018

UPDATE 1-Russian nod moves Bayer closer to wrapping up Monsanto deal

* Cash call signals Bayer's confidence in deal going ahead (Adds remedies, previous reviews, background on Russia, cash call)

Apr 20 2018

BRIEF-Bayer Details Conditions Of Russian Approval Of Monsanto Deal

* CONDITION FOR RUSSIAN APPROVAL WAS TRANSFER OF DEFINED TECHNOLOGIES TO RUSSIAN RECIPIENTS IN THE AREA OF SEEDS BREEDING, DIGITAL FARMING FOR 5 YEARS

Apr 20 2018

Bayer says Russia grants antitrust clearance for Monsanto takeover

FRANKFURT, April 20 Russia's antitrust regulator FAS has approved Bayer's planned $62.5 billion takeover of Monsanto, a Bayer spokesman said on Friday. (Reporting by Ludwig Burger Editing by Maria Sheahan)

Apr 20 2018

Russia gives green light to Bayer's takeover of Monsanto: Ifax

MOSCOW Russia's anti-monopoly regulator FAS has approved Bayer's takeover of Monsanto , Russian news agency Interfax reported on Friday, citing the regulator.

Apr 20 2018

Russia gives green light to Bayer's takeover of Monsanto - Ifax

MOSCOW, April 20 Russia's anti-monopoly regulator FAS has approved Bayer's takeover of Monsanto, Russian news agency Interfax reported on Friday, citing the regulator. (Reporting by Maria Kiselyova Editing by Edmund Blair)

Apr 20 2018

BRIEF-Evotec Says Endometriosis Programme With Bayer Moves To Phase I Development

* DGAP-NEWS: EVOTEC AND BAYER ADVANCE THIRD ENDOMETRIOSIS PROGRAMME INTO PHASE I CLINICAL DEVELOPMENT Source text for Eikon: Further company coverage:

Apr 18 2018

U.S. senators seek review of Marfrig's deal to buy National Beef

CHICAGO Four U.S. senators asked a national security panel on Tuesday to review whether Marfrig Global Foods SA's planned $969 million acquisition of Missouri-based National Beef Packing Co [NBEEF.UL] threatens the safety of the U.S. food supply.

Apr 17 2018

U.S. senators seek review of Marfrig's deal to buy National Beef

CHICAGO, April 17 Four U.S. senators asked a national security panel on Tuesday to review whether Marfrig Global Foods SA's planned $969 million acquisition of Missouri-based National Beef Packing Co threatens the safety of the U.S. food supply.

Apr 17 2018

BRIEF-Compugen Ltd - Bayer Plans To Advance Cancer Immunotherapy Program Into First-In-Human Trials In 2018

* COMPUGEN LTD - BAYER PLANS TO ADVANCE CANCER IMMUNOTHERAPY PROGRAM INTO FIRST-IN-HUMAN TRIALS IN 2018 Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)

Apr 17 2018

Earnings vs. Estimates